Loading clinical trials...
Loading clinical trials...
Hepatitis C Virus is liver disease and is a leading cause of death and morbidity with around 71 million people affected worldwide. Widespread availability of highly effective direct-acting antivirals ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07388979 · HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus), and more
NCT04577482 · Hepatitis C Virus (HCV)
NCT02219490 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT02167945 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT04189627 · Hepatitis C Virus (HCV)
Centre de soin d'accompagnement et de prevention en addictologie- CHU Archet 2 /ID# 218682
Nice, Alpes-Maritimes
Centre de Soins d'Accompagnement et de Prevention en Addictologie-Tempo Oppelia /ID# 218701
Valence, Drome
CSAPA Bagnols sur ceze /ID# 233397
Bagnols-sur-Cèze, Gard
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions